The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorden, K. B.
Right arrow Articles by Vasilakos, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorden, K. B.
Right arrow Articles by Vasilakos, J. P.
The Journal of Immunology, 2005, 174: 1259-1268.
Copyright © 2005 by The American Association of Immunologists

Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8

Keith B. Gorden, Kevin S. Gorski, Sheila J. Gibson, Ross M. Kedl1, William C. Kieper, Xiaohong Qiu, Mark A. Tomai, Sefik S. Alkan and John P. Vasilakos2

3M Pharmaceuticals, St. Paul, MN 55144

Although TLR7 and TLR8 are phylogenetically and structurally related, their relative functions are largely unknown. The role of TLR7 has been established using TLR7-deficient mice and small molecule TLR7 agonists. The absence of TLR8-selective agonists has hampered our understanding of the role of TLR8. In this study TLR agonists selective for TLR7 or TLR8 were used to determine the repertoire of human innate immune cells that are activated through these TLRs. We found that TLR7 agonists directly activated purified plasmacytoid dendritic cells and, to a lesser extent, monocytes. Conversely, TLR8 agonists directly activated purified myeloid dendritic cells, monocytes, and monocyte-derived dendritic cells (GM-CSF/IL-4/TGF-{beta}). Accordingly, TLR7-selective agonists were more effective than TLR8-selective agonists at inducing IFN-{alpha}- and IFN-regulated chemokines such as IFN-inducible protein and IFN-inducible T cell {alpha} chemoattractant from human PBMC. In contrast, TLR8 agonists were more effective than TLR7 agonists at inducing proinflammatory cytokines and chemokines, such as TNF-{alpha}, IL-12, and MIP-1{alpha}. Thus, this study demonstrated that TLR7 and TLR8 agonists differ in their target cell selectivity and cytokine induction profile.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. Forsbach, J.-G. Nemorin, C. Montino, C. Muller, U. Samulowitz, A. P. Vicari, M. Jurk, G. K. Mutwiri, A. M. Krieg, G. B. Lipford, et al.
Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
J. Immunol., March 15, 2008; 180(6): 3729 - 3738.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. P. Gantier, S. Tong, M. A. Behlke, D. Xu, S. Phipps, P. S. Foster, and B. R. G. Williams
TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages
J. Immunol., February 15, 2008; 180(4): 2117 - 2124.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. R. Cruz, M. W. Moore, C. J. La Vake, C. H. Eggers, J. C. Salazar, and J. D. Radolf
Phagocytosis of Borrelia burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytes
Infect. Immun., January 1, 2008; 76(1): 56 - 70.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Salio, A. O. Speak, D. Shepherd, P. Polzella, P. A. Illarionov, N. Veerapen, G. S. Besra, F. M. Platt, and V. Cerundolo
Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation
PNAS, December 18, 2007; 104(51): 20490 - 20495.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Z. Dudek, C. Yunis, L. I. Harrison, S. Kumar, R. Hawkinson, S. Cooley, J. P. Vasilakos, K. S. Gorski, and J. S. Miller
First in Human Phase I Trial of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Cancer
Clin. Cancer Res., December 1, 2007; 13(23): 7119 - 7125.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C.-L. Ku, H. von Bernuth, C. Picard, S.-Y. Zhang, H.-H. Chang, K. Yang, M. Chrabieh, A. C. Issekutz, C. K. Cunningham, J. Gallin, et al.
Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity
J. Exp. Med., October 1, 2007; 204(10): 2407 - 2422.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. D. Marshall, D. S. Heeke, M. L. Gesner, B. Livingston, and G. Van Nest
Negative regulation of TLR9-mediated IFN-{alpha} induction by a small-molecule, synthetic TLR7 ligand
J. Leukoc. Biol., September 1, 2007; 82(3): 497 - 508.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Thomas, C. Laxton, J. Rodman, N. Myangar, N. Horscroft, and T. Parkinson
Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus Infection
Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2969 - 2978.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
L. I. Harrison, C. Astry, S. Kumar, and C. Yunis
Pharmacokinetics of 852A, an Imidazoquinoline Toll-Like Receptor 7-Specific Agonist, Following Intravenous, Subcutaneous, and Oral Administrations in Humans
J. Clin. Pharmacol., August 1, 2007; 47(8): 962 - 969.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Lore, W. C. Adams, M. Havenga, M. L. Precopio, L. Holterman, J. Goudsmit, and R. A. Koup
Myeloid and Plasmacytoid Dendritic Cells Are Susceptible to Recombinant Adenovirus Vectors and Stimulate Polyfunctional Memory T Cell Responses
J. Immunol., August 1, 2007; 179(3): 1721 - 1729.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Alter, T. J. Suscovich, N. Teigen, A. Meier, H. Streeck, C. Brander, and M. Altfeld
Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells
J. Immunol., June 15, 2007; 178(12): 7658 - 7666.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Severa, M. E. Remoli, E. Giacomini, V. Annibali, V. Gafa, R. Lande, M. Tomai, M. Salvetti, and E. M. Coccia
Sensitization to TLR7 Agonist in IFN-beta-Preactivated Dendritic Cells
J. Immunol., May 15, 2007; 178(10): 6208 - 6216.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
K. Hattermann, S. Picard, M. Borgeat, P. Leclerc, M. Pouliot, and P. Borgeat
The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis
FASEB J, May 1, 2007; 21(7): 1575 - 1585.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
O. Levy
Bruton tyrosine kinase (Btk): key for signaling via Toll-like receptor 8
Blood, March 15, 2007; 109(6): 2273 - 2274.
[Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Hamm, A. Heit, M. Koffler, K. M. Huster, S. Akira, D. H. Busch, H. Wagner, and S. Bauer
Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo
Int. Immunol., March 1, 2007; 19(3): 297 - 304.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
E. Assier, V. Marin-Esteban, A. Haziot, E. Maggi, D. Charron, and N. Mooney
TLR7/8 agonists impair monocyte-derived dendritic cell differentiation and maturation
J. Leukoc. Biol., January 1, 2007; 81(1): 221 - 228.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wang, Y. Shao, T. A. Bennett, R. A. Shankar, P. D. Wightman, and L. G. Reddy
The Functional Effects of Physical Interactions among Toll-like Receptors 7, 8, and 9
J. Biol. Chem., December 8, 2006; 281(49): 37427 - 37434.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Flacher, M. Bouschbacher, E. Verronese, C. Massacrier, V. Sisirak, O. Berthier-Vergnes, B. de Saint-Vis, C. Caux, C. Dezutter-Dambuyant, S. Lebecque, et al.
Human Langerhans Cells Express a Specific TLR Profile and Differentially Respond to Viruses and Gram-Positive Bacteria
J. Immunol., December 1, 2006; 177(11): 7959 - 7967.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. K. B. Gorden, X. Qiu, J. J. L. Battiste, P. P. D. Wightman, J. P. Vasilakos, and S. S. Alkan
Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines
J. Immunol., December 1, 2006; 177(11): 8164 - 8170.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. K. B. Gorden, X. X. Qiu, C. C. A. Binsfeld, J. P. Vasilakos, and S. S. Alkan
Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides
J. Immunol., November 15, 2006; 177(10): 6584 - 6587.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
R. S. Kornbluth and G. W. Stone
Immunostimulatory combinations: designing the next generation of vaccine adjuvants
J. Leukoc. Biol., November 1, 2006; 80(5): 1084 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
G. E. Morris, L. C. Parker, J. R. Ward, E. C. Jones, M. K. B. Whyte, C. E. Brightling, P. Bradding, S. K. Dower, and I. Sabroe
Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses
FASEB J, October 1, 2006; 20(12): 2153 - 2155.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. J. Gibbard, P. J. Morley, and N. J. Gay
Conserved Features in the Extracellular Domain of Human Toll-like Receptor 8 Are Essential for pH-dependent Signaling
J. Biol. Chem., September 15, 2006; 281(37): 27503 - 27511.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
J. R. Inglefield, C. J. Larson, S. J. Gibson, H. Lebrec, and R. L. Miller
Apoptotic Responses in Squamous Carcinoma and Epithelial Cells to Small-Molecule Toll-like Receptor Agonists Evaluated with Automated Cytometry
J Biomol Screen, September 1, 2006; 11(6): 575 - 585.
[Abstract] [PDF]

Home page
 BloodHome page
O. Levy, E. E. Suter, R. L. Miller, and M. R. Wessels
Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells
Blood, August 15, 2006; 108(4): 1284 - 1290.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
K. S. Rosenthal and D. H. Zimmerman
Vaccines: all things considered.
Clin. Vaccine Immunol., August 1, 2006; 13(8): 821 - 829.
[Full Text] [PDF]

Home page
 Int ImmunolHome page
K. S. Gorski, E. L. Waller, J. Bjornton-Severson, J. A. Hanten, C. L. Riter, W. C. Kieper, K. B. Gorden, J. S. Miller, J. P. Vasilakos, M. A. Tomai, et al.
Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists
Int. Immunol., July 1, 2006; 18(7): 1115 - 1126.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
U. Wille-Reece, B. J. Flynn, K. Lore, R. A. Koup, A. P. Miles, A. Saul, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, et al.
Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates
J. Exp. Med., May 15, 2006; 203(5): 1249 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
T. Querec, S. Bennouna, S. Alkan, Y. Laouar, K. Gorden, R. Flavell, S. Akira, R. Ahmed, and B. Pulendran
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
J. Exp. Med., February 21, 2006; 203(2): 413 - 424.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Lee, C. C. N. Wu, K. J. Lee, T.-H. Chuang, K. Katakura, Y.-T. Liu, M. Chan, R. Tawatao, M. Chung, C. Shen, et al.
Activation of anti-hepatitis C virus responses via Toll-like receptor 7
PNAS, February 7, 2006; 103(6): 1828 - 1833.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. M. Prins, N. Craft, K. W. Bruhn, H. Khan-Farooqi, R. C. Koya, R. Stripecke, J. F. Miller, and L. M. Liau
The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor Immunity
J. Immunol., January 1, 2006; 176(1): 157 - 164.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
U. Wille-Reece, B. J. Flynn, K. Lore, R. A. Koup, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, and R. A. Seder
HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates
PNAS, October 18, 2005; 102(42): 15190 - 15194.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Lindstedt, K. Lundberg, and C. A. K. Borrebaeck
Gene Family Clustering Identifies Functionally Associated Subsets of Human In Vivo Blood and Tonsillar Dendritic Cells
J. Immunol., October 15, 2005; 175(8): 4839 - 4846.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.